These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8025209)

  • 21. Type I diabetes mellitus. A chronic autoimmune disease.
    Eisenbarth GS
    N Engl J Med; 1986 May; 314(21):1360-8. PubMed ID: 3517648
    [No Abstract]   [Full Text] [Related]  

  • 22. T cell reconstitution of BB/W rats after the initiation of insulitis precipitates the onset of diabetes.
    Ramanathan S; Poussier P
    J Immunol; 1999 May; 162(9):5134-42. PubMed ID: 10227984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
    Zhang ZJ; Davidson L; Eisenbarth G; Weiner HL
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10252-6. PubMed ID: 1946445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-dependent diabetes mellitus as an autoimmune disease.
    Bach JF
    Endocr Rev; 1994 Aug; 15(4):516-42. PubMed ID: 7988484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current and past prevention and intervention trials in type 1 diabetes.
    Staeva T
    Novartis Found Symp; 2008; 292():99-109; discussion 109-12, 122-9, 202-3. PubMed ID: 19203095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of pre-insulin dependent diabetes.
    Gottlieb PA; Eisenbarth GS
    Annu Rev Med; 1998; 49():391-405. PubMed ID: 9509271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?
    Rabinovitch A
    Diabetes; 1994 May; 43(5):613-21. PubMed ID: 8168635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen.
    Laloux V; Beaudoin L; Jeske D; Carnaud C; Lehuen A
    J Immunol; 2001 Mar; 166(6):3749-56. PubMed ID: 11238616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin dependent diabetes mellitus hypothesis of autoimmunity.
    Rossini AA; Handler ES; Greiner DL; Mordes JP
    Autoimmunity; 1991; 8(3):221-35. PubMed ID: 1932509
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
    Vaysburd M; Lock C; McDevitt H
    J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 diabetes mellitus as a polygenic multifactorial disease: immunopathogenic mechanisms of beta-cell destruction.
    Dotta F; Fondelli C; Di Mario U
    Acta Biomed; 2005; 76 Suppl 3():14-8. PubMed ID: 16915790
    [No Abstract]   [Full Text] [Related]  

  • 32. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice.
    Robey IF; Peterson M; Horwitz MS; Kono DH; Stratmann T; Theofilopoulos AN; Sarvetnick N; Teyton L; Feeney AJ
    J Immunol; 2004 Apr; 172(7):4624-9. PubMed ID: 15034081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is prevention of type I diabetes mellitus feasible?].
    Thivolet C
    Diabete Metab; 1994; 20(2 Pt 2):235-9. PubMed ID: 8001710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific therapeutic attempts in experimental and clinical type-I diabetes.
    Federlin K; Becker F
    Klin Wochenschr; 1990; 68 Suppl 21():38-43. PubMed ID: 2198389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.
    Simmons K; Michels AW
    Rheum Dis Clin North Am; 2014 Nov; 40(4):797-811. PubMed ID: 25437293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model.
    Mathieu C; Bouillon R; Rutgeerts O; Waer M
    Transplant Proc; 1995 Feb; 27(1):640-1. PubMed ID: 7879129
    [No Abstract]   [Full Text] [Related]  

  • 40. Ligand-dependent induction of noninflammatory dendritic cells by anergic invariant NKT cells minimizes autoimmune inflammation.
    Wang J; Cho S; Ueno A; Cheng L; Xu BY; Desrosiers MD; Shi Y; Yang Y
    J Immunol; 2008 Aug; 181(4):2438-45. PubMed ID: 18684934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.